- Home
- MAG vs CPRX Comparison
MAG vs CPRX Comparison
Compare MAG & CPRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MAG
- CPRX
- Stock Information
- Founded
- MAG N/A
- CPRX 2002
- Country
- MAG Canada
- CPRX United States
- Employees
- MAG N/A
- CPRX N/A
- Industry
- MAG Precious Metals
- CPRX Biotechnology: Pharmaceutical Preparations
- Sector
- MAG Basic Materials
- CPRX Health Care
- Exchange
- MAG Nasdaq
- CPRX Nasdaq
- Market Cap
- MAG 2.2B
- CPRX 2.6B
- IPO Year
- MAG N/A
- CPRX 2006
- Fundamental
- Price
- MAG $22.88
- CPRX $20.07
- Analyst Decision
- MAG Hold
- CPRX Strong Buy
- Analyst Count
- MAG 3
- CPRX 5
- Target Price
- MAG $22.67
- CPRX $33.20
- AVG Volume (30 Days)
- MAG 1.1M
- CPRX 1.4M
- Earning Date
- MAG 08-11-2025
- CPRX 08-06-2025
- Dividend Yield
- MAG 2.38%
- CPRX N/A
- EPS Growth
- MAG 67.82
- CPRX 183.96
- EPS
- MAG 0.99
- CPRX 1.65
- Revenue
- MAG N/A
- CPRX $558,499,000.00
- Revenue This Year
- MAG N/A
- CPRX $16.37
- Revenue Next Year
- MAG N/A
- CPRX $8.80
- P/E Ratio
- MAG $23.07
- CPRX $12.18
- Revenue Growth
- MAG N/A
- CPRX 28.55
- 52 Week Low
- MAG $11.72
- CPRX $19.00
- 52 Week High
- MAG $23.42
- CPRX $26.58
- Technical
- Relative Strength Index (RSI)
- MAG 65.43
- CPRX 40.47
- Support Level
- MAG $22.74
- CPRX $19.36
- Resistance Level
- MAG $23.42
- CPRX $20.51
- Average True Range (ATR)
- MAG 0.58
- CPRX 0.74
- MACD
- MAG 0.18
- CPRX -0.06
- Stochastic Oscillator
- MAG 93.79
- CPRX 27.22
About MAG MAG Silver Corporation
MAG Silver Corp is a Canadian mining company. It is focused on advancing high-grade, district-scale precious metals projects in the Americas. The Company's principal asset is in the Juanicipio Mine located in Zacatecas, Mexico, which produced around 4,000 tonnes per day commercially. The company is also Interested in the Larder project. Its operations are Juanicipio, Deer Trail, and Larder. The Juanicipio Mine recognizes silver, gold, lead, and zinc revenue from concentrate sales.
About CPRX Catalyst Pharmaceuticals Inc.
Catalyst Pharmaceuticals Inc is a biopharmaceutical company. It focuses on developing and commercializing, developing therapies for people with rare, debilitating, chronic neuromuscular and neurological diseases. It offers three drug products, FIRDAPSE (amifampridine), FYCOMPA (perampanel), and AGAMREE (vamorolone).